Transform Myeloma Virtual Series

Multiple myeloma is a complex and challenging cancer that affects the plasma cells in the bone marrow. Despite advances in treatment, patients with relapsed or refractory disease often face limited options, especially after multiple lines of therapy. A promising approach for these patients is the use of bispecific T-cell engagers (BiTEs), which are designed to target specific proteins on myeloma cells and activate the immune system to fight the disease.
This webinar series will focus on the clinical application of these innovative therapies, examining their mechanism of action, efficacy, and safety profile. Through discussions on recent clinical trials and real-world case studies, healthcare professionals will gain valuable insights into the latest advancements in multiple myeloma treatment and how these therapies can be integrated into clinical practice.

Transform Myeloma Virtual Series is prepared & led by Saudi Myeloma Working Group.